Charles Schwab’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $790M | Buy |
|
|||||
|
2025
Q1 | $836M | Buy |
|
|||||
|
2024
Q4 | $670M | Buy |
|
|||||
|
2024
Q3 | $756M | Buy |
|
|||||
|
2024
Q2 | $753M | Buy |
|
|||||
|
2024
Q1 | $651M | Buy |
|
|||||
|
2023
Q4 | $614M | Buy |
|
|||||
|
2023
Q3 | $510M | Buy |
|
|||||
|
2023
Q2 | $510M | Buy |
|
|||||
|
2023
Q1 | $455M | Buy |
|
|||||
|
2022
Q4 | $409M | Buy |
|
|||||
|
2022
Q3 | $402M | Buy |
|
|||||
|
2022
Q2 | $384M | Buy |
|
|||||
|
2022
Q1 | $346M | Buy |
|
|||||
|
2021
Q4 | $277M | Buy |
|
|||||
|
2021
Q3 | $225M | Buy |
|
|||||
|
2021
Q2 | $245M | Buy |
|
|||||
|
2021
Q1 | $259M | Sell |
|
|||||
|
2020
Q4 | $298M | Sell |
|
|||||
|
2020
Q3 | $352M | Buy |
|
|||||
|
2020
Q2 | $359M | Buy |
|
|||||
|
2020
Q1 | $277M | Buy |
|
|||||
|
2019
Q4 | $247M | Buy |
|
|||||
|
2019
Q3 | $188M | Buy |
|
|||||
|
2019
Q2 | $196M | Buy |
|
|||||
|
2019
Q1 | $195M | Buy |
|
|||||
|
2018
Q4 | $162M | Buy |
|
|||||
|
2018
Q3 | $180M | Buy |
|
|||||
|
2018
Q2 | $154M | Sell |
|
|||||
|
2018
Q1 | $158M | Buy |
|
|||||
|
2017
Q4 | $143M | Buy |
|
|||||
|
2017
Q3 | $141M | Buy |
|
|||||
|
2017
Q2 | $115M | Buy |
|
|||||
|
2017
Q1 | $80.8M | Buy |
|
|||||
|
2016
Q4 | $51.3M | Buy |
|
|||||
|
2016
Q3 | $58.4M | Buy |
|
|||||
|
2016
Q2 | $56.2M | Buy |
|
|||||
|
2016
Q1 | $50.6M | Buy |
|
|||||
|
2015
Q4 | $78.7M | Buy |
|
|||||
|
2015
Q3 | $61.6M | Buy |
|
|||||
|
2015
Q2 | $71.6M | Buy |
|
|||||
|
2015
Q1 | $65.6M | Buy |
|
|||||
|
2014
Q4 | $63.3M | Buy |
|
|||||
|
2014
Q3 | $55.7M | Buy |
|
|||||
|
2014
Q2 | $46.1M | Buy |
|
|||||
|
2014
Q1 | $32.8M | Buy |
|
|||||
|
2013
Q4 | $33.6M | Buy |
|
|||||
|
2013
Q3 | $34M | Buy |
|
|||||
|
2013
Q2 | $14.3M | Buy |
|